戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  longest duration in those with fungal (13), arboviral (10), and bacterial meningitis (7).
2 sion rate at 30 days was 3.2%; patients with arboviral (12.7%), bacterial (6.7%), and fungal (5.4%) e
3 ose with bacterial (8.2%), fungal (8.2%), or arboviral (8.9%) disease.
4 a commensal bacterium critical for efficient arboviral acquisition.
5 KV epidemic representing just one of several arboviral agents moving through the population.
6 cularly Culex quinquefasciatus are important arboviral and filariasis vectors, however despite this i
7 ded solution for preventing new outbreaks of arboviral and parasitic diseases in anthropic environmen
8                                              Arboviral and rodent-borne infections are considered a p
9  Rift Valley fever virus (RVFV), an emerging arboviral and zoonotic bunyavirus, causes severe disease
10  cell biology, and applications to filarial, arboviral, and agricultural diseases.
11 cly available and user-friendly database for arboviral case data in the Americas: ARCA.
12                     Users can choose to view arboviral case data through a table which containscontai
13 insecticide campaigns responding to reported arboviral cases and by the emergence of insecticide resi
14 uerto Rico using three indicators: suspected arboviral cases, suspected Zika-associated Guillain-Barr
15 nd environmental investigations suggested an arboviral cause.
16 perspective is essential to address emerging arboviral challenges, particularly in the context of a c
17  assessed the role of sylvatic reservoirs in arboviral circulation by examining serological evidence
18 -PCR) assay in urine or blood in an enhanced arboviral clinical surveillance site.
19 sting alternate causes or the involvement of arboviral cofactors in exacerbating microcephaly rates.
20 eking activity, thus providing a strategy of arboviral control.
21  macaques in sustaining and amplifying urban arboviral cycles; rather, low-level macaque seropositivi
22                   Patients on rituximab with arboviral disease can have a severe or prolonged course
23 rituximab therapy who were diagnosed with an arboviral disease caused by West Nile, tick-borne enceph
24 ue virus, DENV-1-4, are the leading cause of arboviral disease globally.
25  virus (EEEV) produces the most severe human arboviral disease in North America (NA) and is a potenti
26 s the leading cause of domestically acquired arboviral disease in the contiguous United States.
27 est Nile virus (WNV) is the leading cause of arboviral disease in the United States and is associated
28 le virus (WNV) is the leading cause of human arboviral disease in the US, peaking during summer.
29                 Dengue is the most prevalent arboviral disease of humans.
30 ular stomatitis is an economically important arboviral disease of livestock.
31 ing surfaces of Aedes aegypti mosquitoes (an arboviral disease vector) in houses, such as exposed low
32 the heterogeneity of exposure to malaria and arboviral disease vectors by national control programs.
33 terogeneity of human exposure to malaria and arboviral disease vectors in an urban area of northern S
34                        Dengue is an emerging arboviral disease where the severity of illness is influ
35                 Dengue is the most prevalent arboviral disease worldwide, and the four dengue virus (
36 he development of novel strategies to combat arboviral disease, including the release of transgenic m
37 gue fever, a prevalent and rapidly spreading arboviral disease, poses substantial public health and e
38 allenges to the treatment of neuropathogenic arboviral disease.
39 V) infection is a re-emerging pandemic human arboviral disease.
40 l practical and theoretical tools to control arboviral disease.
41  seen an unprecedented emergence of epidemic arboviral diseases (notably dengue, chikungunya, yellow
42                             Surveillance for arboviral diseases among febrile patients was performed
43                                              Arboviral diseases are a growing global health concern.
44                                         Many arboviral diseases are uncontrolled, and the viruses tha
45 I IFNs underlie an increasing list of severe arboviral diseases due to Flaviviridae (WNV, TBEV, POWV,
46          The escalating global prevalence of arboviral diseases emphasizes the need to improve our un
47 e describe how current approaches to mapping arboviral diseases have become unnecessarily siloed, ign
48 nical findings of patients on rituximab with arboviral diseases identified through literature review
49 y offer new strategies for the prevention of arboviral diseases in the future.
50  virus (EEEV) produces the most severe human arboviral diseases in the United States, with mortality
51                                              Arboviral diseases pose major economic and social threat
52 E With half of the human population at risk, arboviral diseases represent a substantial global health
53          Aedes aegypti is the main vector of arboviral diseases such as dengue, chikungunya and Zika.
54                                 For decades, arboviral diseases were considered to be only minor cont
55 tions known to be effective against multiple arboviral diseases will offer the most cost-effective an
56 ctive competence in the main vector of human arboviral diseases, Aedes aegypti We report a JH-mediate
57 ounted by reported cases, such as influenza, arboviral diseases, and leptospirosis.
58 xciting potential new form of biocontrol for arboviral diseases, including dengue.
59 osquito Aedes aegypti is the major vector of arboviral diseases, particularly of Dengue fever, of whi
60 ors is important in preventing the spread of arboviral diseases, providing a timely indicator of path
61 obal threat of mosquito and tick-transmitted arboviral diseases.
62 d to the simultaneous increase and spread of arboviral diseases.
63 g lymphatic filariasis (LF), as well as many arboviral diseases.
64 s since become one of the best-characterized arboviral diseases.
65 eting inflammasome function could help treat arboviral diseases.
66  transmits the pathogens of Lyme and several arboviral diseases.
67 r mosquito, Aedes aegypti, a major vector of arboviral diseases.
68 layers in the epidemiology of many important arboviral diseases.
69 or vectors of dengue, chikungunya, and other arboviral diseases.
70 y obligate host alternation and predict that arboviral emergence via host range changes may be less f
71 virus (LACV), the leading cause of pediatric arboviral encephalitis in North America, and other ortho
72 virus (LACV) is a primary cause of pediatric arboviral encephalitis in the United States, particularl
73 virus (WNV) is the leading cause of epidemic arboviral encephalitis in the United States.
74 AC) virus is an important cause of pediatric arboviral encephalitis in the United States.
75                                              Arboviral encephalitis is a potentially devastating huma
76 WV-infected BALB/c mice demonstrated typical arboviral encephalitis, characterized by paresis and par
77 of this paper is to review lessons from past arboviral epidemics and determine how these observations
78   The accurate forecasting of mosquito-borne arboviral epidemics will help minimize their impact on u
79       Our ARCA database is a useful tool for arboviral epidemiology research allowing for complex que
80 n 1999, has been responsible for the largest arboviral epiornitic and epidemic of human encephalitis
81 opulation bottlenecks and founder effects in arboviral evolution and spread, and the emergence of hum
82 ts for broad-spectrum antivirals in multiple arboviral families.
83 ved regions in these proteomes, although the arboviral Flaviviridae are a notable exception where non
84 nisms of Rift Valley fever (RVF), a zoonotic arboviral haemorrhagic fever, at both local and broader
85 Valley fever (RVF) is an emerging, zoonotic, arboviral hemorrhagic fever threatening livestock and hu
86 m samples from 346 patients with a suspected arboviral illness were tested using a multiplex real-tim
87 nt assays (ELISAs) for the detection of anti-arboviral immunoglobulin G (IgG ELISAs) were developed f
88  aegypti abundances and laboratory-confirmed arboviral incidence with variable accuracy (28-85% for v
89 e served as a test of how the probability of arboviral incursion into new regions is assessed and has
90 ophagous nature of mosquitoes contributes to arboviral infection after a blood meal, which suppresses
91 irus (LACV) is the most common neuroinvasive arboviral infection in children in the United States.
92 ntibiotic depletion of gut bacteria impaired arboviral infection of a lab-adapted Aedes aegypti mosqu
93                    Dengue is the most common arboviral infection of humans, responsible for a substan
94                    Dengue is the most common arboviral infection of humans.
95 dicating that GABA signaling facilitates the arboviral infection of mosquitoes.
96                             The diagnosis of arboviral infection required molecular testing in 20 (95
97 ell response against dengue virus (DenV), an arboviral infection that afflicts >50 million individual
98                      Zika virus (ZIKV) is an arboviral infection that has been shown to be sexually t
99                                  Dengue is a arboviral infection that represents a major global healt
100                    S. marcescens facilitates arboviral infection through a secreted protein named SmE
101     Dengue virus has emerged as an important arboviral infection worldwide.
102                    Dengue is the most common arboviral infection, causing substantial morbidity and m
103   Consistently, inoculation of GABA enhanced arboviral infection, indicating that GABA signaling faci
104 tients had serological evidence for a recent arboviral infection.
105 rological disease and a history of suspected arboviral infection.
106 rtant role in host immune responses early in arboviral infection.
107 ting more than two billion people at risk of arboviral infection.
108 ) of 201 patients had laboratory evidence of arboviral infection.
109  serologic and viral testing for evidence of arboviral infection.
110 al protection that reduce the probability of arboviral infection.
111 owed by invasive bacterial infections (17%), arboviral infections (13%), and malaria (9%).
112                                              Arboviral infections are an important cause of emerging
113                                              Arboviral infections are frequent causes of febrile illn
114 nical and epidemiological characteristics of arboviral infections during the introduction and spread
115                   Clinicians should consider arboviral infections in unexplained meningoencephalitis
116  in the treatment of LACV and, more broadly, arboviral infections of the central nervous system.
117                                        Viral/arboviral infections were characterized by a pattern of
118      The increasing prevalence of tick-borne arboviral infections worldwide necessitates advanced con
119  health tool for assessing the risk of human arboviral infections, allocating limited public health r
120 diseases that may be rare, or in the case of arboviral infections, often have variable seasonal and g
121                                              Arboviral infections, particularly Dengue and Zika, cont
122  the early detection and management of these arboviral infections, particularly in resource-limited s
123 s; or into etiologic agent groups, including arboviral Infections, Viral Syndromes, and Blood and Tis
124 ere standardized for laboratory diagnosis of arboviral infections, with the intent that they be used
125 -Abs can also underlie severe forms of rarer arboviral infections.
126  of Aedes aegypti mosquitoes to disseminated arboviral infections.
127 , West Nile virus has produced the 3 largest arboviral neuroinvasive disease outbreaks ever recorded
128             However, diagnosing and treating arboviral neurologic disease remains difficult, largely
129                  Virus detection using MSSPE arboviral or haemorrhagic fever viral panels was compara
130  large and poorly sampled epidemics, such as arboviral or respiratory virus outbreaks, and validate i
131 type for the initial infection and spread of arboviral orthobunyaviruses.
132                     Research associated with arboviral outbreaks has provided an understanding of the
133 l of chikungunya and other Aedes-transmitted arboviral outbreaks.
134  novel transmission barrier tools to prevent arboviral outbreaks.
135 e virus (DENV) is the most significant human arboviral pathogen and causes approximately 400 million
136           In June 2006, bluetongue virus, an arboviral pathogen of ruminants, appeared in northern Eu
137 ift Valley fever virus (RVFV) is an emerging arboviral pathogen that causes disease in both livestock
138 des aegypti mosquitoes are deadly vectors of arboviral pathogens and breed in containers of freshwate
139 f immunoglobulin antibody binding against 10 arboviral pathogens from a cross-sectional study in nort
140 primary mosquito vector for dengue and other arboviral pathogens.
141 nt of dual-acting therapeutics against these arboviral pathogens.
142 a reverse transcriptase was found to amplify arboviral RNA directly from Q-paper, without requiring a
143 of the patients but no dengue virus or other arboviral RNA.
144                                      Current arboviral serology assays are either labor intensive or
145                              Furthermore, an arboviral serology was done in 169 (49%) patients and me
146 sa fever, highlighting the need for expanded arboviral surveillance and diagnostics to distinguish em
147 ngolan Ministry of Health as part of routine arboviral surveillance were tested by real-time reverse
148  emerged as one of the most important global arboviral threats in the last decade.
149 ress towards understanding the mechanisms of arboviral transmission and acquisition by mosquitoes.
150 reservoirs, such as macaques, in maintaining arboviral transmission remains unclear.
151 of novel vector control strategies to combat arboviral transmission, including genetic versions of th
152 ever, little is known about the influence on arboviral transmission.
153 vents during periods of intense, concomitant arboviral transmission.
154 of hematophagous arthropods is essential for arboviral transmission.
155                                       In the arboviral vector Aedes aegypti, adaptation to anthropoge
156                   We address this gap in the arboviral vector Aedes aegypti.
157 RNA levels within reproductive organs of the arboviral vector mosquito, Aedes aegypti, prompting us t
158   The coexistence of An. stephensi and Aedes arboviral vectors offers an optimal opportunity for succ

 
Page Top